Product

Introduction to Gastro-resistant Rabeprazole and Domperidone Prolonged-release Capsules The Gastro-resistant Rabeprazole and Domperidone Prolonged-release Capsules are a combination medication used to manage conditions like gastroesophageal reflux disease (GERD), peptic ulcer disease, and related symptoms such as heartburn, nausea, vomiting, and gastric acidity. The capsule contains Rabeprazole, which is an acid-labile proton pump inhibitor that reduces gastric acid secretion, and Domperidone, a prokinetic agent that enhances stomach and intestinal motility to prevent acid reflux. The gastro-resistant and prolonged-release formulation of this combination product helps protect the active ingredients from the acidic environment of the stomach and ensures a controlled, extended release to provide effective relief from GERD and related symptoms. This combination therapy is particularly beneficial for GERD patients with delayed gastric emptying and hypotensive esophageal sphincter, as the Domperidone component helps improve gastric motility and lower esophageal sphincter tone, thereby preventing the reflux of gastric contents into the esophagus.

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat, vel illum dolore eu feugiat nulla facilisis at vero eros et accumsan et iusto odio dignissim qui blandit praesent luptatum zzril delenit augue duis dolore te feugait nulla facilisi.
Lorem ipsum dolor sit amet, cons ectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat.